Benmohamed
Lbachir Benmohamed, Mission Viejo, CA US
Patent application number | Description | Published |
---|---|---|
20080299140 | Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv Condition - Immunogenic composition comprising at least one Herpes Simplex Virus type 1 (HSV-1) and/or type 2 (HSV-2) peptide sequence hearing at least one epitope from glycoprotein D (gD) and/or glycoprotein B (gB), a pharmaceutical carrier and/or a human compatible adjuvant, peptide sequences and uses thereof for prevention or treatment of an HSV condition. | 12-04-2008 |
Lotfi Benmohamed, Clarksville, MD US
Patent application number | Description | Published |
---|---|---|
20090103501 | Decentralized Media Access Control for Ad-Hoc Mobile Wireless Network - A method of operating a decentralized ad-hoc wireless network including wireless stations, comprises establishing a common time reference which is used by the wireless stations to share access to a common wireless channel, the common time reference having a periodic superframe structure including a Scheduled Beacon Period, a Contended Beacon Period, Contention Periods (CPs) and Contention Free Periods (CFPs). The method further comprises time-scheduling, using wireless communication between the wireless stations, the CFPs in the SBTT interval to at least some of the wireless stations requesting access to the CFPs, and granting access to the CPs to at least some of the wireless stations requesting access to the CPs. | 04-23-2009 |
20100246549 | System and Methods for Distributed Medium Access Control and QOS Scheduling in Mobile Ad-Hoc Networks - A communication device and method are provided for communicating with a receiving device over a channel within a mobile ad-hoc network. The receiving device includes a clear-to-send (CTS) packet generating portion that can generate and a CTS packet based on a parameter of the channel and that can transmit the CTS packet over the channel. The communication device includes a transmitter portion, a receiver portion and a management portion. The transmitter portion can transmit information into the channel. The receiver portion can receive information from the channel. The management portion includes a request-to-send (RTS) packet generating portion, a CTS packet receiving portion, a threshold database, a comparator and an RES packet generating portion. The management portion is in communication with the transmitter portion and the receiver portion. The RTS packet generating portion can generate a RTS packet and can provide the RTS packet to the transmitter portion. The transmitter portion can transmit the RTS packet to the receiving device by way of the channel. The receiver portion can receive the CTS packet from the receiving device by way of the channel and can provide the CTS packet to the CTS packet receiving portion. The threshold database can store a threshold value for the parameter of the channel and can provide the threshold value to the comparator. The CTS packet receiving portion can provide channel parameter information, to the comparator, based on the CTS packet. The comparator can compare the threshold value and the channel parameter information and can generate an instruction signal based on the comparison. The RES packet generating portion can generate an RES packet based on the instruction signal and can provide the RES packet to the transmitter portion. | 09-30-2010 |
Lotfi M. Benmohamed, Clarksville, MD US
Patent application number | Description | Published |
---|---|---|
20100129078 | OPTICAL TRANSMISSION SYSTEMS, DEVICES, AND METHODS - Optical communications systems including grooming, protection, restoration, and migration on a unified network platform, and using a unified control plane. The systems may include combinations of optical bypass and mesh restoration, may include combinations of shared mesh and dedicate protection, and may be combinations of long haul, extended long haul, and ultra long haul systems. The systems may also include a configurable DWDM tier to accommodate dynamic traffic patterns, thereby allowing for increased operational flexibility. | 05-27-2010 |
Radhia Benmohamed, Tewksbury, MA US
Patent application number | Description | Published |
---|---|---|
20110237907 | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS - The present invention relates to the identification of compounds and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided compounds. | 09-29-2011 |
20120035203 | BUTACLAMOL FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS - The present invention relates to the use of butaclamol and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. | 02-09-2012 |
20120046309 | PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS - The present invention relates to the identification of inventive pyrimidine-2,4,6-triones (PYT compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the inventive PYT compounds. | 02-23-2012 |
20120264765 | Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis - The present invention relates to the identification of provided cyclohexane-1,3-diones (CHD compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided CHD compounds. | 10-18-2012 |
20140371313 | Cyclohexane-1,3-Diones for Use in the Treatment of Amyotrophic Lateral Sclerosis - The present invention relates to the identification of provided cyclohexane-1,3-diones (CHD compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided CHD compounds. | 12-18-2014 |